日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

BilT03: Phase 1b/2 multicenter trial of nivolumab with 5-fluorouracil and liposomal irinotecan for previously treated advanced biliary tract cancer

BilT03：一项针对既往接受过治疗的晚期胆道癌患者的纳武利尤单抗联合5-氟尿嘧啶和脂质体伊立替康的1b/2期多中心试验

期刊:Med
影响因子:11.8
doi:10.1016/j.medj.2024.10.024
Sahai, Vaibhav; Griffith, Kent A; Lin, Bruce S; Soares, Heloisa P; Chandana, Sreenivasa R; Crysler, Oxana; Kumar-Sinha, Chandan; Enzler, Thomas; Dippman, Dominique; Gunchick, Valerie; Zalupski, Mark M
肿瘤
肿瘤免疫
胆管癌
发表日期：2025
文献求助 收藏

Characterization of undifferentiated carcinomas of the pancreas with and without osteoclast-like giant cells

对伴有和不伴有破骨细胞样巨细胞的胰腺未分化癌进行表征

期刊:JNCI Cancer Spectrum
影响因子:4.1
doi:10.1093/jncics/pkae097
Mills, Jamie N; Gunchick, Valerie; McGue, Jake; Qin, Zhaoping; Kumar-Sinha, Chandan; Bednar, Filip; Brown, Noah; Shi, Jiaqi; Udager, Aaron M; Frankel, Timothy; Zalupski, Mark M; Sahai, Vaibhav
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Pursuing theranostics: a multimodal architecture approach

追求诊疗一体化：一种多模态架构方法

期刊:Sensors & Diagnostics
影响因子:3.5
doi:10.1039/d4sd00221k
Bender, Aidan A; Holiski, Connor K; Embree, Mary; Hennkens, Heather M; Klaehn, John R; Lundgreen, Ellie; Roberts, Andrew G; Zalupski, Peter R; Mastren, Tara
发表日期：2025
文献求助 收藏

A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

一项针对转移性胰腺导管腺癌患者的Ib/II期随机临床试验，评估奥莱克鲁单抗联合或不联合度伐利尤单抗及化疗的疗效

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-0499
Coveler, Andrew L; Reilley, Matthew J; Zalupski, Mark; Macarulla, Teresa; Fountzilas, Christos; Ponz-Sarvisé, Mariano; Nagrial, Adnan; Uboha, Nataliya V; Frentzas, Sophia; Overman, Michael; Noonan, Anne; Messersmith, Wells A; Pavlakis, Nick; Mettu, Niharika B; Bisha, Ina; Wang, Ying; Smith, Paul; Murtomaki, Elina; Bielska, Agata A; Bragulat, Veronique; Cooper, Zachary A; Kumar, Rakesh; Spigel, David R
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma

PARP抑制剂治疗IDH1突变型胆管癌患者

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae163
Mohan, Arathi; Quingalahua, Elit; Gunchick, Valerie; Paul, Simi; Kumar-Sinha, Chandan; Crysler, Oxana; Zalupski, Mark M; Sahai, Vaibhav
PARP
肿瘤
胆管癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

替莫唑胺或替莫唑胺联合卡培他滨治疗晚期胰腺神经内分泌肿瘤患者的随机研究（ECOG-ACRIN E2211）

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.01013
Kunz, Pamela L; Graham, Noah T; Catalano, Paul J; Nimeiri, Halla S; Fisher, George A; Longacre, Teri A; Suarez, Carlos J; Martin, Brock A; Yao, James C; Kulke, Matthew H; Hendifar, Andrew E; Shanks, James C; Shah, Manisha H; Zalupski, Mark M; Schmulbach, Edmond L; Reidy-Lagunes, Diane L; Strosberg, Jonathan R; O'Dwyer, Peter J; Benson, Al B 3rd
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Devimistat联合吉西他滨和顺铂治疗胆道癌：临床前评估和Ib期多中心临床试验（BilT-04）

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-0036
Mohan, Arathi; Griffith, Kent A; Wuchu, Fulei; Zhen, David B; Kumar-Sinha, Chandan; Crysler, Oxana; Hsiehchen, David; Enzler, Thomas; Dippman, Dominique; Gunchick, Valerie; Achreja, Abhinav; Animasahun, Olamide; Choppara, Srinadh; Nenwani, Minal; Chinnaiyan, Arul M; Nagrath, Deepak; Zalupski, Mark M; Sahai, Vaibhav
肿瘤
胆管癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy

对 1140 例胆道癌患者进行生存分析，评估其在接受全身治疗的同时使用肾素-血管紧张素拮抗剂、他汀类药物或阿司匹林治疗的获益。

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad063
Gunchick, Valerie; McDevitt, Rachel L; Choi, Elizabeth; Winslow, Katherine; Zalupski, Mark M; Sahai, Vaibhav
肿瘤
胆管癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Tuning aminopolycarboxylate chelators for efficient complexation of trivalent actinides

优化氨基多羧酸螯合剂以实现三价锕系元素的高效络合

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-44106-6
Pilgrim, Corey D; Grimes, Travis S; Smith, Clayn; Heathman, Colt R; Mathew, Jopaul; Jansone-Popova, Santa; Roy, Santanu; Ray, Debmalya; Bryantsev, Vyacheslav S; Zalupski, Peter R
发表日期：2023
文献求助 收藏

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01

一项针对既往未接受治疗的晚期胆道癌患者的随机 II 期试验，比较纳武利尤单抗、吉西他滨和顺铂或纳武利尤单抗联合伊匹木单抗的疗效：BilT-01

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.34394
Sahai, Vaibhav; Griffith, Kent A; Beg, Muhammad S; Shaib, Walid L; Mahalingam, Devalingam; Zhen, David B; Deming, Dustin A; Zalupski, Mark M
肿瘤
胆管癌
肿瘤免疫
发表日期：2022
文献求助 收藏